Table 3.
Risk of Hard Endpoints and Lesion-Oriented Composite Outcome Across the 4-Group Categories
| Group 2 | Group 3 | Group 4 | |
|---|---|---|---|
| Hard endpoints | HR (95% CI); P value | ||
| vs Group 1 | 4.093 (3.118-5.374); P < 0.001 | 1.547 (1.059-2.261); P = 0.024 | 5.673 (4.054-7.938); P < 0.001 |
| vs Group 2 | 0.378 (0.261-0.549); P < 0.001 | 1.387 (1.001-1.923); P = 0.050 | |
| vs Group 3 | 3.592 (2.358-5.473); P < 0.001 | ||
| LOCO | HR (95% CI); P value | ||
| vs Group 1 | 1.980 (1.296-3.025); P = 0.002 | 4.194 (2.949-5.963); P < 0.001 | 5.811 (3.786-8.921); P < 0.001 |
| vs Group 2 | 2.108 (1.383-3.213); P = 0.001 | 2.953 (1.815-4.803); P < 0.001 | |
| vs Group 3 | 1.409 (0.92-2.159); P = 0.115 | ||
Hard endpoints = defined as all-cause death and myocardial infarction; LOCO = lesion-oriented composite outcome, defined as target lesion revascularization, target-vessel myocardial infarction.